Prenetics Global - Class A opened lower at $17.50, compared with its previous close of $17.64. In the last trading session, the stock traded between $16.30 and $17.83. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Prenetics Global - Class A is now worth
$ 14.57
Resulting in a loss of
$ 85.43 (85.43%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 6 Analysts
Buy
100%
Hold
0%
Sell
0%
Markets Today
Today's Change
$-0.92 (-5.23%)
Day High
$17.83
Day Low
$16.30
Day Open
$17.50
Prev Close
$17.64
Volume
1,12,107
1W Return
3.85%
1M Return
-21.45%
3M Return
-12.13%
6M Return
-4.75%
1Y Return
29.29%
Fundamentals
Market Cap ($ Mn)
260
PE Ratio
-
PB Ratio
4.72
PEG Ratio
-
ROE
-22.65%
ROCE
-22.12%
EPS (TTM)
$-0.54
Investment Returns
1 Week
3.85%
1 Month
-21.45%
3 Months
-12.13%
6 Months
-4.75%
9 Months
-21.88%
Financials
Quarterly
All values in $ Mn
17.3
Mar 25
17.7
Jun 25
23.6
Sep 25
36.6
Dec 25
36.0
Mar 26
46.5
Jun 26
Updates
26Oct
Maxim Group initiates coverage on Prenetics Global with Buy rating
Maxim Group initiated coverage on Prenetics Global. Analyst Thomas Forte assigned a Buy rating. Price target set at $41 per share.
17 days ago
7Oct
Prenetics CEO eyes acquisitions as IM8 targets $400m sales by 2027
Prenetics Global CEO Danny Yeung is exploring acquisitions to acquire new customers. David Beckham-backed brand IM8 plans a U.S. retail launch in 2027. IM8's FY27 sales target of $400 million+ is described as conservative by management.
1mo ago
21Sep
Prenetics Global Q2FY26 Results: Revenue up 3.9x, guidance raised
Prenetics Global Q2 revenue rose 3.9x YoY to $46.5 million. Full-year revenue guidance raised to $220-230 million range. Adjusted free cash flow turned positive in July for first time. Company secured $1 billion growth financing from General Catalyst. New customer acquisition cost fell 21% in July to $239.
1mo ago
26Aug
Prenetics CEO Yeung And CFO Rosin Buy $1M In Shares Post Q2 Results
Prenetics executives Danny Yeung and Brian Rosin bought $1.0 million in shares in August 2026. CEO Yeung's cumulative investment reaches $1.75 million since November 2025. CFO Rosin made his first open market purchase since joining in May 2026. Q2FY26 revenue rose 288% YoY to $46.5 million driven by IM8 brand growth.
2mo ago
20Aug
Prenetics signs Lily Collins as IM8 global ambassador and shareholder
Prenetics signs Lily Collins as IM8 global ambassador and shareholder. Collins brings 33M+ social followers with ~5.9% engagement rate. FY26 revenue guidance raised to $220-$230 million. FY27 revenue guidance initiated at $400+ million. IM8 ships ~200,000 servings daily across 46 countries.
2mo ago
18Aug
Prenetics Global FY26 Sales Guidance of $220M-$230M Beats $214M Estimate
Prenetics Global forecasts FY26 sales between $220.000 million and $230.000 million, beating the $214.071 million analyst estimate. The guidance implies a minimum 2.8% upside to consensus, reflecting strong underlying business momentum.
